Moreover, Sparcl1 can induce and regulate CCL2 to activate an inflammatory response, filling the gap in the field of glycoproteins in NASH (Liu B. et al., 2021). This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.